A family of cytokine-inducible inhibitors of signalling

被引:1789
作者
Starr, R
Willson, TA
Viney, EM
Murray, LJL
Rayner, JR
Jenkins, BJ
Gonda, TJ
Alexander, WS
Metcalf, D
Nicola, NA
Hilton, DJ
机构
[1] ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, PARKVILLE, VIC 3052, AUSTRALIA
[2] COOPERAT RES CTR CELLULAR GROWTH FACTORS, PARKVILLE, VIC 3052, AUSTRALIA
[3] INST MED & VET SCI, HANSON CTR CANC RES, ADELAIDE, SA 5000, AUSTRALIA
关键词
D O I
10.1038/43206
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cytokines are secreted proteins that regulate important cellular responses such as proliferation and differentiation(1). Key events in cytokine signal transduction are well defined: cytokines induce receptor aggregation, leading to activation of members of the JAK family of cytoplasmic tyrosine kinases. In turn, members af the STAT family of transcription factors are phosphorylated, dimerize and increase the transcription of genes with STAT recognition sites in their promoters(1-4). Less is known of how cytokine signal transduction is switched off. We have cloned a complementary DNA encoding a protein SOCS-1, containing an SH2-domain, by its ability to inhibit the macrophage differentiation of M1 cells in response to interleukin-6. Expression of SOCS-1 inhibited both interleukin-6-induced receptor phosphorylation and STAT activation. We have also cloned two-relatives of SOCS-1, named SOCS-2 and SOCS-3, which together with the previously described CIS (ref. 5) form a new family of proteins. Transcription of all four SOCS genes is increased rapidly in response to interleukin-6, in vitro and in vivo, suggesting they may act in a classic negative feedback loop to regulate cytokine signal transduction.
引用
收藏
页码:917 / 921
页数:5
相关论文
共 30 条
[1]   POINT MUTATIONS WITHIN A DIMER INTERFACE HOMOLOGY DOMAIN OF C-MPL INDUCE CONSTITUTIVE RECEPTOR ACTIVITY AND TUMORIGENICITY [J].
ALEXANDER, WS ;
METCALF, D ;
DUNN, AR .
EMBO JOURNAL, 1995, 14 (22) :5569-5578
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]  
[Anonymous], METHOD ENZYMOL
[4]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[5]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[6]  
FENG J, IN PRESS MOL CELL BI
[7]  
Hilton DJ, 1996, J BIOL CHEM, V271, P4699
[8]   CLONING OF A MURINE IL-11 RECEPTOR ALPHA-CHAIN - REQUIREMENT FOR GP130 FOR HIGH-AFFINITY BINDING AND SIGNAL-TRANSDUCTION [J].
HILTON, DJ ;
HILTON, AA ;
RAICEVIC, A ;
RAKAR, S ;
HARRISONSMITH, M ;
GOUGH, NM ;
BEGLEY, CG ;
METCALF, D ;
NICOLA, NA ;
WILLSON, TA .
EMBO JOURNAL, 1994, 13 (20) :4765-4775
[9]   CYTOKINE RECEPTOR SIGNALING [J].
IHLE, JN .
NATURE, 1995, 377 (6550) :591-594
[10]   SIGNALING THROUGH THE HEMATOPOIETIC CYTOKINE RECEPTORS [J].
IHLE, JN ;
WITTHUHN, BA ;
QUELLE, FW ;
YAMAMOTO, K ;
SILVENNOINEN, O .
ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 :369-398